Actinium Pharmaceuticals, Inc. | ||||
ASE : ATNM || Location: United States | ||||
$6.56-0.5 (-7.08%) |
0.33 M | 6.47 - 6.97 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
April 15, 2024 | 1.977 M |
March 28, 2024 | 2.187 M |
March 15, 2024 | 1.823 M |
Feb. 29, 2024 | 1.804 M |
Feb. 15, 2024 | 1.863 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.55 | -0.34 | 38.27% |
09/30/2023 | -0.54 | -0.49 | 9.64% |
06/30/2023 | -0.49 | -0.58 | -18.46% |
03/31/2023 | -0.43 | -0.43 | 0.42% |
12/31/2022 | -0.36 | -0.43 | -18.75% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 29.396M | Shares Float | 28.609M |
Short Float | 1.977M | Market Cap | 192.84M |
Institution ownership | 24.62% | Insider ownership | 2.162% |
Earnings Date | 05/15/2024 AMC | Cash Per Share | ? |
Trailing EPS | -1.83 | Forward EPS | -0.11 |